Evidence map›Paper›PMID 18437155›Full record

ReviewNature reviews. Immunology2008

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Charles N Serhan, Nan Chiang, Thomas E Van Dyke

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,423 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,423citing papers in PubMed, 5 pooled it
104.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02317588 phase1completednot on this mapstarted 2014, after this paper: background citation

Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans

TypeinterventionalSponsorUniversity of ManitobaRan2014 to 2016Enrolled12ConditionsHealthyArmsFlax Oil, Fish Oil
NCT02683850 early_phase1completednot on this mapstarted 2016, after this paper: background citation

Influence of an Omega-3 SPM Supplement on Quality of Life

TypeinterventionalSponsorNational University of Natural MedicineRan2016 to 2016Enrolled44ConditionsChronic PainArmsOmega-3 SPM™ softgel
NCT03208920 nacompletednot on this mapstarted 2016, after this paper: background citation

Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.

TypeinterventionalSponsorUniversity of California, San FranciscoRan2016 to 2018Enrolled2ConditionsPAD, Abdominal Aortic AneurysmArmsPro-Omega, ProOmega Placebo
3 · Its place in the literature

Who cites it

1,423 citing papers in PubMed, 5 syntheses or guidelines pooled it, 2,869 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

1,363 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Charles N SerhanCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. cnserhan@zeus.bwh.harvard.edu
Nan Chiang
Thomas E Van Dyke
Boston University · USBrigham and Women's Hospital · USHarvard University · US

Funding

Specialized Center for Oral Inflammation and ResolutionP50DE016191 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2004 to 2010
$13.6M
BLOOD CELL LIPOXYGENASE PRODUCTS: FORMATION AND ACTIONR01GM038765 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 1992 to 2020
$4.9M
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTIONR37GM038765 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2000 to 2009
$4.0M
PHAGOCYTE RESOLVING METABOLISMR01DK074448 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2005 to 2009
$1.5M
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION &ACTIONR29GM038765 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 1987 to 1991
–
NIDCR NIH HHS P50 DE016191NIDCR NIH HHS P50-DE016191NIDDK NIH HHS DK074448NIDDK NIH HHS R01 DK074448NIGMS NIH HHS GM38765NIGMS NIH HHS R01 GM038765NIGMS NIH HHS R37 GM038765
6 · The paper itself

Abstract

Active resolution of acute inflammation is a previously unrecognized interface between innate and adaptive immunity. Once thought to be a passive process, the resolution of inflammation is now shown to involve active biochemical programmes that enable inflamed tissues to return to homeostasis. This Review presents new cellular and molecular mechanisms for the resolution of inflammation, revealing key roles for eicosanoids, such as lipoxins, and recently discovered families of endogenous chemical mediators, termed resolvins and protectins. These mediators have anti-inflammatory and pro-resolution properties, thereby protecting organs from collateral damage, stimulating the clearance of inflammatory debris and promoting mucosal antimicrobial defence.

Indexed as

AnimalsCD59 AntigensEicosanoidsEicosapentaenoic AcidHumansImmunity, ActiveImmunity, InnateInflammationInflammation MediatorsLipoxinsMucous MembraneSignal TransductionCD59 AntigensEicosanoidsEicosapentaenoic AcidInflammation MediatorsLipoxins

Identifiers

PMID18437155
PMCPMC2744593
OpenAlexW2103010344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.